Bristol-Myers Squibb Co (NYSE:BMY)
| 60.43 Delayed Data As of Mar 05 |  +1.09 / +1.84%Today’s Change | 45.76 Today|||52-Week Range 67.16 | -2.58% Year-to-Date |
Latest BMY News | Press Releases
| Why Is Bristol Myers (BMY) Down 1.8% Since Last Earnings Report? Mar 06 / Zacks.com - Paid Partner Content | 5 Stocks Warren Buffett Just Sold From Berkshire's Portfolio Mar 04 / MotleyFool.com - Paid Partner Content |
| Top Stock Reports for Mastercard, NVIDIA & Costco Mar 05 / Zacks.com - Paid Partner Content | Acceleron (XLRN) Q4 Loss Wider Than Expected, Revenues Beat Mar 01 / Zacks.com - Paid Partner Content |
| Amgen (AMGN) to Add Stomach Cancer Drug With Five Prime Buyout Mar 05 / Zacks.com - Paid Partner Content | Hotchkis & Wiley's Top 5 Trades of the 4th Quarter Mar 01 / GuruFocus News - Paid Partner Content |
| ETFs to Tap Amgen's Drive for Cancer Deal Mar 05 / Zacks.com - Paid Partner Content | 3 Top Stocks That'll Make You Richer in March (and Beyond) Mar 01 / MotleyFool.com - Paid Partner Content |
| Why Pfizer Is Still a Top Stock for 2021 Mar 05 / MotleyFool.com - Paid Partner Content | Retail, Tech Earnings, and Berkshire's Surprising Buys Feb 27 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 59.34 |
| Today’s open | 60.53 |
| Day’s range | 59.34 - 60.59 |
| Volume | 14,980,107 |
| Average volume (3 months) | 11,601,301 |
| Market cap | $135.4B |
Data as of 4:00pm ET, 03/05/2021
Growth & Valuation
| Earnings growth (last year) | -297.94% |
| Earnings growth (this year) | +16.18% |
| Earnings growth (next 5 years) | +6.76% |
| Revenue growth (last year) | +62.62% |
| P/E ratio | NM |
| Price/Sales | 3.29 |
| Price/Book | 3.59 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | +0.83 | +1.76% |
| NVONovo Nordisk | +0.45 | +0.65% |
| SNYSanofi | +0.65 | +1.42% |
| GSKGlaxoSmithKline | +0.62 | +1.81% |
Data as of 4:00pm ET, 03/05/2021
Financials
| Next reporting date | April 29, 2021 |
| EPS forecast (this quarter) | $1.81 |
| Annual revenue (last year) | $42.5B |
| Annual profit (last year) | -$9.0B |
| Net profit margin | -21.20% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
